SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-029134
Filing Date
2018-11-13
Accepted
2018-11-13 07:58:20
Documents
3
Period of Report
2018-11-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K Q3 2018 EARNING RELEASE nvus-8k_20181113.htm 8-K 28659
2 EX-99.1 - EARNINGS RELEASE nvus-ex991_15.htm EX-99.1 196914
3 GRAPHIC glbt450s5n30000001.jpg GRAPHIC 3745
  Complete submission text file 0001564590-18-029134.txt   232128
Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Novus Therapeutics, Inc. (Filer) CIK: 0001404281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36620 | Film No.: 181175195
SIC: 2834 Pharmaceutical Preparations